Karin Eurenius

• Team lead with 3 approved patents including regulatory affairs (FDA), product strategy, safety and compliance, 9 pending publications and an international spin-off company for sustainable energy, medical and clinical research, carrying out entrepreneurship focusing on international business strategy, marketing influence, identify new business opportunities to enable further business development, business planning and business analysis towards industry • Multidisciplinary team leadership for 30 people within life science and biotechnology end-to-end projects, with full strategy, budget and hiring responsibility, to focus on novel ways to handle bioanalytics data within amongst others oncology projects on basis of kinetics characterization with in vivo samples using a range of cell, molecular and biochemical techniques • Global communication lead due to solid presentation and written communication skills, developing applied research areas by reviewing white papers, writing proposals and presenting findings to non-scientific clients and boards to gain funding, and reporting results at numerous conferences as chair or invited or keynote speaker • The business impact was a device at 17% of the market competitor manufacturing cost, which could be sold at twice the price for the current competitor, using 10% of the energy compared to original device, where focus was centred around customer experience and environmental monitoring